Labetalol

Overview

Labetalol (HCl) is oral and parenteral competitive cocdirselective ß -adrenergic and selective postsynaptic a-1 adrenergic receptor blocker. Due to the presence of two optical centers, there are four diastereoisomers of labetolol, each of which displays different relative activities. The drug mixture possesses three to seven times greater ß -blocking activity than a-1 -blocking activity. Labetalol is clinically used in the treatment of hypertension associated with a variety of conditions. Labetalol was approved by the FDA for use in August 1984. Labetalol (HCl) is a reversible ß blocker with concurrent a1 blocking actions that produces peripheral vasodialation.lt blocks ß1-receptors in the heart, ß 2-receptors in bronchial and vascular smooth muscle, and a 1receptors in vascular smooth muscle. The ß-blocking activity is three to seven times as potent as the a-blocking ability.The result of labetalol's actions at a- and ß-receptors leads to vasodilation and decreased total peripheral resistance, which results in decreased blood pressure without a substantial decrease in resting heart rate, cardiac output, or stroke volume

Categories

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Labetalol's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

10 to 20 mg15 (15)As recommended.With increasements of 5 to 10 mg if satisfactory hypotension is not acheived after 5 minutes.
15 to 20 mg/hr18 (17.5)As recommended.Iv infusionInitial rate & gradually increased to a dose of 120 mg/hr in hypertention after myocardial infection & 160 mg for hypertension hour in pregnancy.
100 to 200 mg150 (150)As recommended.oralTwice per day.
100 mg100 (100)12 hourlyoralInitially with food.
2.85 to 34.28 mg/kg19 (18.565)As recommended.POAs Required

Paedriatic Dosage (20kg)

0.5 to 0 mg/kg/hour0.25 (0.25)As recommended.To maximum of 3mg/kg/hour,For 1 month to 12 years.
30 to 0 mg/hour15 (15)As recommended.12-18 years.

Neonatal Dosage (3kg)

No data regarding the neonatal dosage details of Labetalol is available.

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Labetalol

Back to top

Manufacturers of Labetalol in Pakistan

Back to top

Previous Drug Generic - Next Drug Generic


Suggested Pages